Book a free demo with us
Book Now
NurExone Biologic
NurExone Biologic Inc. is a publicly-traded biopharmaceutical company, listed on the Toronto Stock Exchange (TSXV: NRX), the OTCQB Venture Market (OTCQB:NRXBF) and Frankfurt Stock Exchange (TSXV: NRX). Developing and commercializing the ExoTherapy platform for production of exosome-loaded nanodrugs.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2020
Haifa, Israel
ISR
USA
Biotechnology
Biotech
Bioinformatics
Medical
- 
https://nurexone.com/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
NurExone Biologic's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Social Media
© 2024 Lucidity Insights.
